These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19159630)

  • 1. Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2'-deoxycytidine.
    Deng T; Zhang Y
    Life Sci; 2009 Feb; 84(9-10):311-20. PubMed ID: 19159630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aza-2'-deoxycytidine reactivates expression of RUNX3 by deletion of DNA methyltransferases leading to caspase independent apoptosis in colorectal cancer Lovo cells.
    Deng T; Zhang Y
    Biomed Pharmacother; 2009 Aug; 63(7):492-500. PubMed ID: 18848767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aza-2'-deoxycytidine induces cytotoxicity in BGC-823 cells via DNA methyltransferase 1 and 3a independent of p53 status.
    Liu J; Zhang Y; Xie YS; Wang FL; Zhang LJ; Deng T; Luo HS
    Oncol Rep; 2012 Aug; 28(2):545-52. PubMed ID: 22664909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
    Pulukuri SM; Rao JS
    Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of 5-Aza-2'-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A).
    Liu J; Xie YS; Wang FL; Zhang LJ; Zhang Y; Luo HS
    Biomed Pharmacother; 2013 Feb; 67(1):78-87. PubMed ID: 23201008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
    Karpf AR; Moore BC; Ririe TO; Jones DA
    Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis.
    Yagi S; Oda-Sato E; Uehara I; Asano Y; Nakajima W; Takeshita T; Tanaka N
    Cancer Invest; 2008 Aug; 26(7):680-8. PubMed ID: 18608210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation.
    Zhu WG; Hileman T; Ke Y; Wang P; Lu S; Duan W; Dai Z; Tong T; Villalona-Calero MA; Plass C; Otterson GA
    J Biol Chem; 2004 Apr; 279(15):15161-6. PubMed ID: 14722112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.
    Liu X; Dai X; Wu B
    Urol Int; 2009; 82(1):108-12. PubMed ID: 19172108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment.
    Wang H; Zhao Y; Li L; McNutt MA; Wu L; Lu S; Yu Y; Zhou W; Feng J; Chai G; Yang Y; Zhu WG
    J Biol Chem; 2008 Feb; 283(5):2564-74. PubMed ID: 17977830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
    Zhang H; Qi F; Cao Y; Zu X; Chen M; Li Z; Qi L
    Cancer Biother Radiopharm; 2013 May; 28(4):343-50. PubMed ID: 23570371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous inhibition of DNA methyltransferase and histone deacetylase induces p53-independent apoptosis via down-regulation of Mcl-1 in acute myelogenous leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Udaka K; Yokoyama A
    Leuk Res; 2011 Jul; 35(7):932-9. PubMed ID: 21550660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of 5-aza-2'-deoxycytidine on cell of high-risk patients with myelodysplastic syndrome in vitro].
    Tong HY; Lin MF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):467-71. PubMed ID: 15363133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine.
    Karpf AR; Lasek AW; Ririe TO; Hanks AN; Grossman D; Jones DA
    Mol Pharmacol; 2004 Jan; 65(1):18-27. PubMed ID: 14722233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Growth and gene expression of leukemia cell after treated with methylation inhibitor 5-aza-2'-deoxycytidine].
    Qiao SK; Xu SR; Guo XN
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):486-90. PubMed ID: 15555266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.
    Schneider-Stock R; Diab-Assef M; Rohrbeck A; Foltzer-Jourdainne C; Boltze C; Hartig R; Schönfeld P; Roessner A; Gali-Muhtasib H
    J Pharmacol Exp Ther; 2005 Feb; 312(2):525-36. PubMed ID: 15547111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inhibition of MEK pathway on 5-aza-deoxycytidine-suppressed pancreatic cancer cell proliferation.
    Wang X; Wang H; Jiang N; Lu W; Zhang XF; Fang JY
    Genet Mol Res; 2013 Nov; 12(4):5560-73. PubMed ID: 24301926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
    Bai T; Tanaka T; Yukawa K; Umesaki N
    Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.